ARTICLE | Clinical News
Provenge sipuleucel-T regulatory update
October 4, 2010 7:00 AM UTC
CMS included several efficacy-related questions in its draft questions posted ahead of a Nov. 17 meeting to discuss Dendreon's Provenge sipuleucel-T prostate cancer therapy. CMS's Medicare Evidence De...